|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
San Francisco, CA, US
|
|
Fee-for-service hit discovery is backwards. Small molecule biotechs should not have to pay when discovery vendors fail to discover potent, developable hits.
OpenBench offers a simple solution. We bear the cost of virtual screening, synthesis, and experimental confirmation, so that our partners only pay for validated hits. This results-driven paradigm fosters partnership and operational efficiency.
We construct hit criteria jointly with partners to ensure outcomes motivate further hit-to-lead pursuit. Once a deal is in place, our partners receive compounds in their labs in 2 months with validation soon to follow.
OpenBench’s technology uniquely enables this results-driven paradigm. We manage scientific risk by picking hits from massive virtual libraries >100x more efficiently than conventional methods. Screening and judiciously filtering billion-compound libraries ensures novelty and developability of hits—traits conventional solutions cannot promise.
To sign up for the OpenBench waitlist, please visit https://opnbnch.com
|
OpenBench Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used OpenBench email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact OpenBench customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.